Cellerant is pleased to be working with Progenitor Cell Therapy for the manufacture of our first product, CLT-001, a highly purified hematopoietic stem cell product for the treatment of genetic blood disorders, cancer, and autoimmune disease. PCT's cell-based manufacturing and regulatory expertise should allow us to move quickly towards our goal of treating patients in 2006.  -   Bruce Cohen     Quotes
Cellerant is pleased to be working with Progenitor Cell Therapy for the manufacture of our first product, CLT-001, a highly purified hematopoietic stem cell product for the treatment of genetic blood disorders, cancer, and autoimmune disease. PCT's cell-based manufacturing and regulatory expertise should allow us to move quickly towards our goal of treating patients in 2006. Bruce Cohen
 Therapy